These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6757593

  • 21. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K.
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract] [Full Text] [Related]

  • 22. [Effects of heparin on HGH secretion after intravenous administration of tolbutamide in normal subjects].
    Ragonese F, Melluso R, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1975-9. PubMed ID: 1231882
    [No Abstract] [Full Text] [Related]

  • 23. [Comparative study of various growth-hormone-secretion stimulation tests in short patients].
    Rodríguez Doreste OL, Cardenal del Valle C, Bosch Millares C.
    Rev Clin Esp; 1977 Dec 15; 147(5):511-4. PubMed ID: 605258
    [No Abstract] [Full Text] [Related]

  • 24. The advantages of combined stimulation by arginine and insulin in the study of the secretion of growth hormone.
    Ruitton A, Tell G, David M, Rocard E.
    Rev Eur Etud Clin Biol; 1972 Nov 15; 17(9):846-54. PubMed ID: 4653986
    [No Abstract] [Full Text] [Related]

  • 25. Decreased arginine-induced HGH response during L-dopa therapy in parkinsonian patients.
    Johnson SE, Norman N, Sjaastad O.
    Acta Endocrinol (Copenh); 1974 Dec 15; 77(4):686-90. PubMed ID: 4479702
    [No Abstract] [Full Text] [Related]

  • 26. [Stimulation of growth hormone (HGH) with L-dopa].
    Gosselin L, Bolduc R, Verreault R.
    Union Med Can; 1974 Sep 15; 103(9):1552-6. PubMed ID: 4439528
    [No Abstract] [Full Text] [Related]

  • 27. Sequential use of insulin and levodopa to provoke pituitary secretion of growth hormone.
    Reiter EO, Root AW, Duckett GE.
    Am J Dis Child; 1977 Feb 15; 131(2):189-91. PubMed ID: 835536
    [Abstract] [Full Text] [Related]

  • 28. Abnormalities in growth hormone and insulin release in short but otherwise normal patients. The arginine-insulin-glucose (AIGT) stimulation and suppression test.
    Raiti S, Maclaren N, Trias E, Kim C.
    Horm Res; 1977 Feb 15; 8(2):93-8. PubMed ID: 908554
    [Abstract] [Full Text] [Related]

  • 29. [Levodopa and somatotropic hormone in diabetes].
    Carducci Artenisio A, Ragonese F, Martelli G, Forte F, Campisi R, Consolo F.
    Boll Soc Ital Biol Sper; 1978 Oct 30; 54(20):1972-7. PubMed ID: 753286
    [No Abstract] [Full Text] [Related]

  • 30. L-dopa, growth hormone and adipokinesis in the lean and the obese.
    Pinter EJ, Tolis G, Friesen HG.
    Int J Clin Pharmacol Biopharm; 1975 Jul 30; 12(1-2):277-80. PubMed ID: 1165135
    [Abstract] [Full Text] [Related]

  • 31. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
    Pontiroli AE, Viberti GC, Tognetti A, Pozza G.
    Horm Metab Res; 1976 Mar 30; 8(2):106-8. PubMed ID: 1261961
    [Abstract] [Full Text] [Related]

  • 32. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 30; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of growth hormone secretion during sleep and after L-dopa.
    Kulesza B, Blaim A, Palińska-Cudnoch M.
    Mater Med Pol; 1977 May 30; 9(1):34-6. PubMed ID: 875451
    [No Abstract] [Full Text] [Related]

  • 34. L-dopa induced plasma glucagon release.
    George DT, Rayfield EJ.
    J Clin Endocrinol Metab; 1974 Sep 30; 39(3):618-21. PubMed ID: 4414050
    [No Abstract] [Full Text] [Related]

  • 35. Glucagon-initiated human growth hormone release: a comparative study.
    Cain JP, Williams GH, Dluhy RG.
    Can Med Assoc J; 1972 Oct 07; 107(7):617-22. PubMed ID: 4665093
    [Abstract] [Full Text] [Related]

  • 36. Growth and growth hormone. IV. Limitations of the growth hormone response to insulin and arginine and of the immunoreactive insulin response to arginine in the assessment of growth hormone deficiency in children.
    Youlton R, Kaplan SL, Grumbach MM.
    Pediatrics; 1969 Jun 07; 43(6):989-1004. PubMed ID: 5786221
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB, Scott CL, Modebe O, Bethune JE.
    J Clin Endocrinol Metab; 1975 Feb 07; 40(2):256-9. PubMed ID: 1117978
    [Abstract] [Full Text] [Related]

  • 38. [Growth hormone concentration during sleep following L-dopa administration].
    Blaim A, Kulesza B, Palinska-Cudnoch M.
    Endokrynol Pol; 1976 Feb 07; 27(5):457-62. PubMed ID: 991841
    [No Abstract] [Full Text] [Related]

  • 39. Study on growth hormone and prolactin secretions in myotonic dystrophy.
    Canal N, Smirne S, Comi G, Guidobono F, Pecile A, Caviezel F.
    Acta Neurol Belg; 1982 Feb 07; 82(3):178-84. PubMed ID: 7051737
    [Abstract] [Full Text] [Related]

  • 40. [Effects of intravenous lipid loading on HGH secretion after administration of L-DOPA].
    Carducci Artenisio A, Ragonese F, Alibrando A, Forte F, Mancuso T, Consolo F.
    Minerva Med; 1979 May 12; 70(23):1681-6. PubMed ID: 109792
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.